These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38838023)

  • 1. Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer's therapy.
    Sai Varshini M; Aishwarya Reddy R; Thaggikuppe Krishnamurthy P
    J Drug Target; 2024 Jun; ():1-9. PubMed ID: 38838023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach.
    Sharma V; Chander Sharma P; Reang J; Yadav V; Kumar Tonk R; Majeed J; Sharma K
    Bioorg Chem; 2024 Jun; 147():107378. PubMed ID: 38643562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoorientin, a GSK-3β inhibitor, rescues synaptic dysfunction, spatial memory deficits and attenuates pathological progression in APP/PS1 model mice.
    Tan X; Liang Z; Li Y; Zhi Y; Yi L; Bai S; Forest KH; Nichols RA; Dong Y; Li QX
    Behav Brain Res; 2021 Feb; 398():112968. PubMed ID: 33069740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
    Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
    J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
    Manoharan SD; Abdul Hamid H; Md Hashim NF; Cheema MS; Chiroma SM; Mustapha M; Mehat MZ
    Brain Res; 2024 Apr; 1829():148793. PubMed ID: 38309553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer's Disease.
    Jia YR; Guo ZQ; Guo Q; Wang XC
    Curr Med Sci; 2023 Oct; 43(5):847-854. PubMed ID: 37721665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer's disease.
    Fronza MG; Alves D; Praticò D; Savegnago L
    Ageing Res Rev; 2023 Sep; 90():102033. PubMed ID: 37595640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer's disease: a novel therapeutic target.
    Mandlik DS; Mandlik SK; S A
    Int J Neurosci; 2024 Jun; 134(6):603-619. PubMed ID: 36178363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3β and its Inhibitors in Alzheimer's Disease: A Recent Update.
    Chauhan N; Paliwal S; Jain S; Verma K; Paliwal S; Sharma S
    Mini Rev Med Chem; 2022; 22(22):2881-2895. PubMed ID: 35450523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
    Kazim SF; Iqbal K
    Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
    Cheng Z; Han T; Yao J; Wang K; Dong X; Yu F; Huang H; Han M; Liao Q; He S; Lyu W; Li Q
    Eur J Med Chem; 2024 Feb; 265():116065. PubMed ID: 38160617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 17beta-estradiol attenuates glycogen synthase kinase-3beta activation and tau hyperphosphorylation in Akt-independent manner.
    Shi HR; Zhu LQ; Wang SH; Liu XA; Tian Q; Zhang Q; Wang Q; Wang JZ
    J Neural Transm (Vienna); 2008 Jun; 115(6):879-88. PubMed ID: 18217188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro.
    Peng X; Guo H; Zhang X; Yang Z; Ruganzu JB; Yang Z; Wu X; Bi W; Ji S; Yang W
    Mol Neurobiol; 2023 May; 60(5):2470-2485. PubMed ID: 36662361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions.
    Kang BW; Kim F; Cho JY; Kim S; Rhee J; Choung JJ
    Alzheimers Res Ther; 2022 Jul; 14(1):92. PubMed ID: 35804462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Wnt and PI3K signaling modulates GSK-3beta activity and induces morphological changes in cortical neurons: role of tau phosphorylation.
    Mercado-Gómez O; Hernández-Fonseca K; Villavicencio-Queijeiro A; Massieu L; Chimal-Monroy J; Arias C
    Neurochem Res; 2008 Aug; 33(8):1599-609. PubMed ID: 18461448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β).
    Goyal S; Singh M; Thirumal D; Sharma P; Mujwar S; Mishra KK; Singh TG; Singh R; Singh V; Singh T; Ahmad SF
    Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β.
    Amin J; Paquet C; Baker A; Asuni AA; Love S; Holmes C; Hugon J; Nicoll JA; Boche D
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):445-57. PubMed ID: 25486988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.